Published in Heart Lung on March 01, 1984
Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations. Aliment Pharmacol Ther (2012) 2.94
Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med (1990) 2.40
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med (1997) 2.20
Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) (2010) 2.18
Endometrial and myometrial thickness and uterine blood flow in postmenopausal women: the influence of hormonal replacement therapy and age. J Ultrasound Med (1993) 2.03
Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med (1981) 1.99
Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity. Ann Intern Med (1970) 1.93
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) (1977) 1.92
Cloning of the human sodium lodide symporter. Biochem Biophys Res Commun (1996) 1.87
Medium-chain triglycerides. N Engl J Med (1969) 1.64
Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab (1997) 1.55
Aspartate and maltose-binding protein interact with adjacent sites in the Tar chemotactic signal transducer of Escherichia coli. J Bacteriol (1992) 1.55
Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab (1971) 1.55
Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes. Endocrinology (1996) 1.52
Hypomagnesemic hypocalcemia secondary to renal magnesium wasting. Ann Intern Med (1975) 1.52
Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med (1992) 1.51
A new rating form for use by nurses in assessing residents' humanistic behavior. J Gen Intern Med (1991) 1.48
Altered subjective appetite parameters in Crohn's disease patients. Clin Nutr (2001) 1.41
Chronic fatigue and acute respiratory failure in a house painter. Hosp Pract (1995) (1997) 1.40
Addressing the spectrum of hypercholesterolemia. Hosp Pract (1995) (1996) 1.39
An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology (1998) 1.34
Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology (1997) 1.32
Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease. Circulation (1968) 1.25
Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab (1997) 1.18
Thyroid storm. A review of 22 episodes with special emphasis on the use of guanethidine. Arch Intern Med (1969) 1.18
Teaching the resident in internal medicine. Present practices and suggestions for the future. JAMA (1986) 1.16
The short cardiac pre-ejection period: an index to thyrotoxicosis. Circulation (1974) 1.16
The pharmacology of sulfonylureas. Am J Med (1981) 1.16
Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab (1975) 1.15
Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol (1987) 1.14
Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature. Dig Dis Sci (1993) 1.13
Sodium iodide symporter in health and disease. Thyroid (2001) 1.09
Papillary and follicular thyroid cancer: a selective approach to diagnosis and treatment. Annu Rev Med (1981) 1.08
Maltose chemotaxis involves residues in the N-terminal and C-terminal domains on the same face of maltose-binding protein. J Biol Chem (1992) 1.05
Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab (1974) 1.04
Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med (1980) 1.02
Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg (2000) 1.00
Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer (2010) 0.99
The ret/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med (1994) 0.98
Use of test strips with colour meter to measure blood-glucose. Lancet (1970) 0.96
Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides. Am J Dig Dis (1976) 0.95
Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology (1977) 0.94
Diazepam (Valium) and thyroid function: a double-blind, placebo controlled study in normal volunteers showing no drug effect. Am J Med Sci (1969) 0.94
Selective release of gastric inhibitory polypeptide by intraduodenal amino acid perfusion in man. Gastroenterology (1978) 0.94
Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion. Gastroenterology (1976) 0.93
Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man. Gastroenterology (1977) 0.93
Renal effects on serum gastric inhibitory polypeptide (GIP). Metabolism (1977) 0.92
Cloning of the human taurine transporter and characterization of taurine uptake in thyroid cells. FEBS Lett (1993) 0.92
Detection of the PTC/retTPC oncogene in human thyroid cancers. Oncogene (1992) 0.92
Benign parotid enlargement in bulimia. Ann Intern Med (1980) 0.92
Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J Clin Endocrinol Metab (2000) 0.92
Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies. Neurosurgery (1993) 0.91
Regulation of monocyte survival in vitro by deposited IgG: role of macrophage colony-stimulating factor. J Immunol (1999) 0.91
Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus. Diabetes (1976) 0.90
Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Hum Mol Genet (1995) 0.89
Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care (1984) 0.89
Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis. Br J Cancer (2010) 0.89
Treatment of hypercalcemia associated with malignancy. Semin Oncol (1978) 0.89
Thyroid cancer and Graves' disease: the controversy ten years later. Endocr Pract (2001) 0.88
Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol (1986) 0.88
Thyroid cancer and Graves' disease. J Clin Endocrinol Metab (1990) 0.87
Treating differentiated thyroid carcinoma: where do we draw the line? Mayo Clin Proc (1991) 0.87
Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene (1999) 0.87
Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci (1982) 0.87
Polyunsaturated fatty acids augment insulin secretion. J Am Coll Nutr (1987) 0.86
Motor nerve conduction in alcoholics. Q J Stud Alcohol (1966) 0.86
Periarticular bone remodeling in rheumatoid arthritis. Calcif Tissue Res (1968) 0.86
Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene. Oncogene (1995) 0.85
Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med (1979) 0.85
Primary empty sella, galactorrhea, hyperprolactinemia and renal tubular acidosis. Am J Med (1975) 0.85
Infectious haematopoietic necrosis virus genogroup-specific virulence mechanisms in sockeye salmon, Oncorhynchus nerka (Walbaum), from Redfish Lake, Idaho. J Fish Dis (2009) 0.85
The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab (1976) 0.84
Histologic variants of papillary thyroid carcinoma. Endocr Pract (2001) 0.84
Can osteoporosis be prevented? Geriatrics (1980) 0.84
Endocrine tumors--special problems in diagnosis and management. Semin Oncol (1987) 0.84
GIP increases insulin receptor affinity and cellular sensitivity in adipocytes. Am J Physiol (1985) 0.84
Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? J Clin Endocrinol Metab (1995) 0.84
Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab (1980) 0.83
Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med (1984) 0.83
A cost and staffing comparison of an all-RN staff and team nursing. Nurs Adm Q (1984) 0.83
RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid (1996) 0.83
Thyrotrophin-producing pituitary adenomas. J Neurosurg (1982) 0.83
Effect of source of dietary carbohydrate on plasma glucose, insulin, and gastric inhibitory polypeptide responses to test meals in subjects with noninsulin-dependent diabetes mellitus. Am J Clin Nutr (1984) 0.83
The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care (1984) 0.83
Thyroid carcinomas in RET/PTC transgenic mice. Recent Results Cancer Res (1998) 0.82
Age and the endocrine system. Clin Geriatr Med (1985) 0.82
Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism (1979) 0.82
Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma. Cancer Lett (1994) 0.82
Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstruction. Am J Dig Dis (1975) 0.82
Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia. Arch Intern Med (1982) 0.82
Papillary and follicular thyroid cancer: selective therapy. Compr Ther (1981) 0.82
Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism (1980) 0.81